Patents for C12R 1 - Micro-organisms (92,025) |
---|
05/02/2002 | US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment |
05/02/2002 | US20020051776 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
05/02/2002 | US20020051775 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
05/02/2002 | US20020051774 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
05/02/2002 | US20020051773 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
05/02/2002 | US20020051772 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
05/02/2002 | EP1201763A2 Production method of polyhydroxyalkanoate from substituted fatty acid ester as raw material |
05/02/2002 | EP1201761A1 Method of constructing recombinant adenovirus vector |
05/02/2002 | EP1201758A1 Microorganisms and method for L-arginine production by fermentation |
05/02/2002 | EP1201757A2 Method for preparing water soluble polypeptides |
05/02/2002 | EP1201756A2 Method for preparing water soluble polypeptides |
05/02/2002 | EP1201748A2 Process for producing alimentary fermentates |
05/02/2002 | EP1201677A1 Novel macrolide compound jk |
05/02/2002 | EP1200615A2 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
05/02/2002 | EP1200611A1 Herbicide-tolerant protoporphyrinogen oxidase |
05/02/2002 | EP1200606A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
05/02/2002 | EP1200605A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
05/02/2002 | EP1200604A1 Production of proteins |
05/02/2002 | EP1200603A1 Production of proteins by autoproteolytic cleavage |
05/02/2002 | EP1200600A2 Monocellular or multicellular organisms for the production of riboflavin |
05/02/2002 | EP1200599A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
05/02/2002 | EP1200568A2 Purine metabolism genes in plants |
05/02/2002 | EP1200566A2 Glucoamylase variant |
05/02/2002 | EP1200565A2 Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
05/02/2002 | EP1200558A2 Avian blastodermal cell lines |
05/02/2002 | EP1200554A2 Materials and methods for the efficient production of pasteuria |
05/02/2002 | EP1200553A1 Metabolic engineering of amino acid production |
05/02/2002 | EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family |
05/02/2002 | EP1200124A1 Immunoglobulin fusion proteins |
05/02/2002 | EP1200114A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
05/02/2002 | EP1200110A1 In vivo induction for enhanced function of isolated hepatocytes |
05/02/2002 | EP1200101A1 Methods for transdifferentiation of body tissues |
05/02/2002 | EP1200083A1 Antibiotic compound |
05/02/2002 | EP0843722A4 Regulated autocrine growth of mammalian cells |
05/02/2002 | EP0455665B1 Hybrid seed production |
05/02/2002 | DE10051175A1 Cytochrom P450 Monoxygenasen aus thermophilen Bakterien Cytochrome P450 monooxygenases from thermophilic bacteria |
05/02/2002 | CA2425000A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
05/01/2002 | CN1347458A Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences |
05/01/2002 | CN1347453A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
05/01/2002 | CN1347451A Polypeptides having branching enzyme activity and nucleic acids encoding same |
05/01/2002 | CN1347450A Composition for preservation of infections recombinant adenoviruses |
05/01/2002 | CN1347421A Antifungal agents isolated from pseudomonas syringae |
05/01/2002 | CN1347400A Microbial process for preparing pravastatin |
05/01/2002 | CN1347391A Bioremediation of petroleum pollutants with alkane-utilizing bacteria |
05/01/2002 | CN1346888A Method for producing transgene non-human mammal |
05/01/2002 | CN1346885A Bacteria and method for producing L-glutamic acid, L-proline or L-arginine |
05/01/2002 | CN1346883A Method for producing high-density antagonistic microbe raw material and raw material produced thereby |
05/01/2002 | CN1083885C Method for producing pravastatin precursor ML-236B |
05/01/2002 | CA2327172A1 Recombinant zymomonas mobilis with improved xylose utilization |
04/30/2002 | US6380462 Method for increasing stearate content in soybean oil |
04/30/2002 | US6380374 Isolated nucleic acid; culture product |
04/30/2002 | US6380360 Polycystic kidney disease 1 gene and uses thereof |
04/30/2002 | US6380355 Process for obtaining insulin precursors having correctly bonded cystine bridges |
04/30/2002 | US6380227 Fermentative preparation process for and crystal forms of cytostatics |
04/30/2002 | US6380160 Gp130 lacking the transmembrane domain |
04/30/2002 | US6380157 Administering medicament comprising papillomavirus l2 protein, or a therapeutically effective fragment thereof for therapy of papillomavirus infection |
04/30/2002 | US6379945 Gene switch |
04/30/2002 | US6379942 Chemically modified enzymes with multiple charged variants |
04/30/2002 | US6379938 Epoxide hydrolase |
04/30/2002 | US6379934 Process for the fermentative preparation of L-amino acids using coryneform bacteria |
04/30/2002 | US6379933 Method of transferring at least two saccharide units with a polyglycosyltransferase |
04/30/2002 | US6379924 Amplifying protein products by using fungal cells having a plasmid with a funcional coding sequence and also having a modified level of ubiquitin conjugating enzymes activity; then culturing the cell to produce a fungal derived product |
04/30/2002 | US6379918 Composition, formulae, devices and methods for control of specificity and inclusivity of microorganisms containing closely related antigen epitopes |
04/30/2002 | US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
04/30/2002 | US6379881 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus |
04/30/2002 | US6379678 Culture product; antiallergens |
04/30/2002 | US6379675 Immunological combination compositions and methods |
04/30/2002 | US6379663 Immunity enhancing lactic acid bacteria |
04/30/2002 | CA2360041A1 Optimisation of fermentation processes |
04/30/2002 | CA2359433A1 Starter production process |
04/30/2002 | CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
04/30/2002 | CA2071908C Antibody antagonists of human interleukin-4 |
04/30/2002 | CA2064689C Stabilized protein or peptide conjugates |
04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
04/25/2002 | WO2002033110A2 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
04/25/2002 | WO2002033109A2 Fermentation method for production of heterologous gene products in lactic acid bacteria |
04/25/2002 | WO2002033098A1 Process for producing viral rna polymerase |
04/25/2002 | WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope |
04/25/2002 | WO2002033057A2 Cytochrome p450 monooxygenases consisting of thermophilic bacteria |
04/25/2002 | WO2002033055A1 Production process and composition of an enzymatic preparation, and its use for the treatment of domestic and industrial effluents of high fat, protein and/or carbohydrate content |
04/25/2002 | WO2001090317A3 Beta-galactosidase isolated from a bifidobacterium |
04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
04/25/2002 | US20020049995 Nucleic acid encoding GAI gene of arbidopsis thaliana |
04/25/2002 | US20020048816 Genetically engineered cell; for use as a vaccine; for use in screening polypeptides and antigens; for use as a support for immobilizing an enzyme, peptide or antigen |
04/25/2002 | US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides |
04/25/2002 | US20020048781 Direct production of desacetylcephalosporin C |
04/25/2002 | US20020048762 Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms |
04/25/2002 | US20020048570 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
04/25/2002 | US20020048569 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
04/25/2002 | US20020048568 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
04/25/2002 | US20020048567 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
04/25/2002 | US20020048562 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
04/25/2002 | CA2426594A1 Production of .alpha.-hydroxy-carboxylic acids using a coupled enzyme system |
04/25/2002 | CA2426084A1 Improved fermentation method for production of heterologous gene products in lactic acid bacteria |
04/25/2002 | CA2425927A1 Cytochrome p450 monooxygenases consisting of thermophilic bacteria |
04/24/2002 | EP1199361A2 Glycoprotein hormone receptor molecules. Their uses |
04/24/2002 | EP1199359A1 Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds |